Xenon Pharmaceuticals Number of Employees 2012-2022 | XENE
Xenon Pharmaceuticals number of employees from 2012 to 2022. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
| Xenon Pharmaceuticals Annual Number of Employees |
| 2021 |
153 |
| 2020 |
129 |
| 2019 |
104 |
| 2018 |
92 |
| 2017 |
81 |
| 2016 |
94 |
| 2015 |
83 |
| 2014 |
74 |
| 2013 |
74 |
| 2012 |
|
| 2011 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$1.635B |
$0.018B |
|
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of medicines through the application of its proprietary discovery platform, which it refer to as Extreme Genetics. Xenon is developing proprietary product candidates for the treatment of both orphan as well as more prevalent diseases. The company offers Glybera (R), a gene therapy for the treatment of lipoprotein lipase deficiency, an orphan disorder. Xenon Pharmaceuticals Inc. is headquartered in Burnaby, Canada.
|
